Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | TP53 | P04637 | 2/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | HTT | P42858 | 2/20 | 0.69 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.68 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.50 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MC4R | P32245 | 1/20 | 0.49 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5088595 | 1.00 | MEN1 (0.71) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| Hydrochloric Acid SCHEMBL5088205 | 1.00 | MEN1 (0.71) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| Hydrochloric Acid SCHEMBL5087607 | 1.00 | MEN1 (0.71) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| Hydrochloric Acid SCHEMBL5087145 | 1.00 | MEN1 (0.71) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| Hydrochloric Acid SCHEMBL5086997 | 1.00 | MEN1 (0.71) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| Hydrochloric Acid SCHEMBL5092098 | 1.00 | MEN1 (0.71) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| Hydrochloric Acid SCHEMBL5085177 | 1.00 | MEN1 (0.71) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| Hydrochloric Acid SCHEMBL5087726 | 0.98 | MEN1 (0.68) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| SCHEMBL11709348 | 0.98 | DNM1 (0.70) | MEN1KMT2ATP53SMN1; SMN2MAPK1 | |
| SCHEMBL16594023 | 0.98 | DNM1 (0.70) | MEN1KMT2ATP53SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044926-B1 | ORAL COMPOSITION FOR DENTAL PURPOSES | NAT UNIV CORPORATION OKAYAMA UNIV (JP) | 2018-01-10 | — | — | EP | disclosed |
| US-8999298-B2 | Dental oral composition | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2015-04-07 | — | — | US | disclosed |
| EP-2241304-B1 | DENTAL ORAL COMPOSITION | UNIV OKAYAMA NAT UNIV CORP (JP) | 2015-03-25 | — | — | EP | disclosed |
| US-8147807-B2 | Oral composition for dental purposes | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20100330005-A1 | DENTAL ORAL COMPOSITION | KURARAY MEDICAL INC. (JP) | 2010-12-30 | — | — | US | disclosed |
| EP-2241304-A1 | DENTAL ORAL COMPOSITION | Kuraray Medical Inc. (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20100240714-A1 | ORAL COMPOSITION FOR DENTAL PURPOSES | NAT. UNI. CORP. OKAYAMA UNIVERSITY (JP) | 2010-09-23 | — | — | US | disclosed |
| EP-2044926-A1 | ORAL COMPOSITION FOR DENTAL PURPOSES | National University Corporation Okayama University (JP) | 2009-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330005-A1 | DENTAL ORAL COMPOSITION | TAS2R42, TAS2R43, PPM1G | MEN1 4469/4885KMT2A 3692/4885TP53 2263/4885 |
| US-20100240714-A1 | ORAL COMPOSITION FOR DENTAL PURPOSES | DDOST, PPM1G, PHOSPHO1 | MEN1 4652/4885KMT2A 4167/4885TP53 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.